FDA label 338a78d2-c23d-0fac-e063-6394a90ab9c4
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- SPL set ID
- 23fa7cb0-590f-2037-e063-6394a90ab7a0
- SPL ID
- 338a78d2-c23d-0fac-e063-6394a90ab9c4
- Version
- 2
- Effective date
- 2025-04-24
- Source export date
- 2026-09-28
- Source partition
- 12
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/663999d0fe1757c1e2cd13a4799d76d875f663e0bc57701092264ebe7febfc18/drug-label-0012-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 06:25:39
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| spl id | 338a78d2-c23d-0fac-e063-6394a90ab9c4 | id | |
| spl set id | 23fa7cb0-590f-2037-e063-6394a90ab7a0 | set_id |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
WARNINGS: For external use only. Not for ophthalmic use. PRECAUTIONS: Allergic Reactions: Hypersensitivity reactions, including severe allergic contact dermatitis and anaphylactic reactions, have been reported with Miconazole use. Discontinue use immediately if signs of hypersensitivity occur. USE IN PREGNANCY: Category C: There are no adequate and well-controlled studies of Miconazole Nitrate or DMSO use in pregnant women. It should be used during pregnancy only if clearly needed.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
ADVERSE REACTIONS: The most common side effects reported during the use of Miconazole-containing products are local irritation, burning, stinging, redness, or swelling at the application site.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.